{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:12:06Z","timestamp":1787065926192,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002377"],"award-info":[{"award-number":["UL1TR002377"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.amjcard.2021.09.025","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T13:08:36Z","timestamp":1635340116000},"page":"80-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Outcomes of Direct Oral Anticoagulants Co-Prescribed with Common Interacting Medications"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9596-7104","authenticated-orcid":false,"given":"David","family":"Sanborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Sugrue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramila","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medhat","family":"Farwati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek J.","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haarini","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1760-7998","authenticated-orcid":false,"given":"Azza","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Asirvatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narith N.","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Noseworthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar M.","family":"Killu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva K.","family":"Mulpuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2831-4568","authenticated-orcid":false,"given":"Malini","family":"Madhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2021.09.025_bib0001","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0002","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0003","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0004","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.115.018544","article-title":"Polypharmacy and the efficacy and safety of rivaroxaban versus warfarin in the prevention of stroke in patients with nonvalvular atrial fibrillation","volume":"133","author":"Piccini","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0005","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1080\/17425255.2016.1225037","article-title":"Drug-drug interactions of non-vitamin K oral anticoagulants","volume":"12","author":"Voukalis","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0006","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jama.2017.13883","article-title":"Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation","volume":"318","author":"Chang","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0007","doi-asserted-by":"crossref","first-page":"i2868","DOI":"10.1136\/bmj.i2868","article-title":"Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial","volume":"353","author":"Jaspers Focks","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0008","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.thromres.2020.08.016","article-title":"Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: a systematic review","volume":"194","author":"Li","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0009","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.amjcard.2020.12.062","article-title":"Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation","volume":"144","author":"Sugrue","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0010","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0011","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12872-020-01340-4","article-title":"Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses","volume":"20","author":"Briasoulis","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0012","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jacc.2014.07.967","article-title":"Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial","volume":"64","author":"Flaker","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0013","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.hrthm.2014.03.006","article-title":"Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial","volume":"11","author":"Steinberg","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0014","doi-asserted-by":"crossref","first-page":"573.e1","DOI":"10.1016\/j.amjmed.2017.11.047","article-title":"Efficacy and safety outcomes of direct oral anticoagulants and amiodarone in patients with atrial fibrillation","volume":"131","author":"Lupercio","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0015","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1093\/eurheartj\/ehv201","article-title":"Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial","volume":"36","author":"Steffel","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0016","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/STROKEAHA.113.000990","article-title":"Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in asians and non-Asians with atrial fibrillation","volume":"44","author":"Hori","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0017","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/STROKEAHA.113.002968","article-title":"Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial","volume":"45","author":"Wong","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0018","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11239-018-1738-7","article-title":"Drug interaction as a predictor of direct oral anticoagulant drug levels in atrial fibrillation patients","volume":"46","author":"Hirsh Raccah","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0019","first-page":"1","article-title":"Antidepressant use in persons aged 12 and over: United States, 2005\u20132008","author":"Pratt","year":"2011","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.102.046532","article-title":"Inhibition of P-glycoprotein by newer antidepressants","volume":"305","author":"Weiss","year":"2003","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0021","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/17425255.2020.1700952","article-title":"Clinically relevant drug interactions between newer antidepressants and oral anticoagulants","volume":"16","author":"Spina","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0022","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/11589340-000000000-00000","article-title":"Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes, and implications for use in elderly patients","volume":"28","author":"de Abajo","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0023","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.amjcard.2014.05.037","article-title":"Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin","volume":"114","author":"Quinn","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2021.09.025_bib0024","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bcp.12541","article-title":"Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor","volume":"79","author":"Frost","year":"2015","journal-title":"Br J Clin Pharmacol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914921009425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914921009425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T11:59:33Z","timestamp":1727438373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914921009425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":24,"alternative-id":["S0002914921009425"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2021.09.025","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Direct Oral Anticoagulants Co-Prescribed with Common Interacting Medications","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2021.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}